Cargando…
The prevalence and importance of frailty in cardiac resynchronization therapy patients
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – EU funding. Main funding source(s): Nemzeti Kardiovaszkuláris Laboratórium RRF-2.3.1-21-2022-00003. BACKGROUND: Frailty, characterized by loss of homeostatic reserves and increased vulnerability to physiological decompensation, res...
Autores principales: | Kuthi, L, Behon, A, Merkel, E, Schwertner, W R, Masszi, R, Veres, B, Kovacs, A, Osztheimer, I, Zima, E, Molnar, L, Geller, L, Kosztin, A, Merkely, B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207441/ http://dx.doi.org/10.1093/europace/euad122.457 |
Ejemplares similares
-
The risk of obesity and the association of body mass index on all-cause mortality after cardiac resynchronization therapy
por: Merkel, E D, et al.
Publicado: (2023) -
The effect of Remote Monitor vs Standard of Care therapy on outcome A systematic review and meta-analysis
por: Veres, B, et al.
Publicado: (2023) -
Predictive value of scar burden assessed by cardiac MRI on sudden cardiac death in cardiac resynchronization therapy patients: a systematic review and meta-analysis
por: Masszi, R, et al.
Publicado: (2023) -
What determines who gets cardiac resynchronization therapy in europe?
por: Gatti, P, et al.
Publicado: (2023) -
Response to cardiac resynchronization therapy and treatment with ARNi and iSGLT2
por: Fonderico, C, et al.
Publicado: (2023)